XML 128 R114.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Financial Information (Parent Company Only) - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating Activities      
Net (loss) income $ (35,168) $ 25,276 $ 8,417
Depreciation and amortization 6,192 8,460 5,748
Share-based compensation expense 1,221 1,814 1,258
Net change in other assets 3,799 (3,932) (6,625)
Net change in other liabilities (3,607) 5,364 (3,158)
Net cash provided by operating activities 3,449 12,992 11,680
Investing activities      
Purchase of equity investments (10,312) (13,583) (4,464)
Net cash used in investing activities 128,681 (496,170) (474,503)
Financing activities      
Cash dividends paid (2,087) (2,078) (2,156)
Repurchase of common stock (521) (283) (9,340)
Other, net (262) (182) (153)
Net cash used in by financing activities (141,763) 543,690 612,169
Net (decrease) increase in cash and cash equivalents (9,633) 60,512 149,346
Cash and cash equivalents, beginning of year 466,410 405,898 256,552
Cash and cash equivalents, end of year 456,777 466,410 405,898
Parent Company      
Operating Activities      
Net (loss) income (35,168) 25,276 8,417
Equity in undistributed net income of subsidiaries 44,807 (15,767) (2,969)
Depreciation and amortization 316 312 318
Share-based compensation expense 397 363 256
Net change in other assets (7,217) 1,506 (1,819)
Net change in other liabilities 8,969 (522) 358
Net cash provided by operating activities 12,104 11,168 4,561
Investing activities      
Purchase of equity investments (7,723) (7,221) (3,578)
Net cash used in investing activities (7,723) (7,221) (3,578)
Financing activities      
Cash dividends paid (2,087) (2,078) (2,156)
Repurchase of common stock (521) (283) (9,340)
Other, net (262) (182) (153)
Net cash used in by financing activities (2,870) (2,543) (11,649)
Net (decrease) increase in cash and cash equivalents 1,511 1,404 (10,666)
Cash and cash equivalents, beginning of year 12,997 11,593 22,259
Cash and cash equivalents, end of year $ 14,508 $ 12,997 $ 11,593